Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
CohBar Inc | CWBR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.761 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.65 - 6.90 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.761 | USD |
CohBar Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 2.21M | - | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CohBar News
Date | Time | Source | News Article |
---|---|---|---|
11/27/2023 | 17:05 | Business Wire | CohBar, Inc.: Notice of Delisting or Failure to Satisfy a.. |
11/27/2023 | 16:21 | Edgar (US Regulatory) | Form 8-K - Current report |
11/13/2023 | 08:01 | Edgar (US Regulatory) | Form 8-K - Current report |
11/01/2023 | 08:05 | Edgar (US Regulatory) | Form 8-K - Current report |
10/25/2023 | 08:01 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
10/25/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
10/06/2023 | 15:13 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
10/06/2023 | 15:11 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
10/04/2023 | 08:14 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
10/04/2023 | 08:12 | Edgar (US Regulatory) | Form 8-K - Current report |
9/12/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
9/12/2023 | 15:47 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CWBR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.8401 | 0.99 | 0.65 | 0.8133621 | 91,690 | -0.0791 | -9.42% |
1 Year | 1.74 | 6.90 | 0.65 | 4.66 | 415,595 | -0.979 | -56.26% |
3 Years | 39.00 | 68.10 | 0.65 | 26.97 | 791,094 | -38.24 | -98.05% |
5 Years | 75.90 | 144.00 | 0.65 | 31.23 | 576,636 | -75.14 | -99.00% |
CohBar Description
CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States. |